The estimated Net Worth of Kenneth S Boger is at least $65.4 Million dollars as of 13 September 2011. Kenneth Boger owns over 22,000 units of Vertex Pharmaceuticals stock worth over $64,089,425 and over the last 21 years Kenneth sold VRTX stock worth over $1,357,708.
Kenneth has made over 17 trades of the Vertex Pharmaceuticals stock since 2003, according to the Form 4 filled with the SEC. Most recently Kenneth exercised 22,000 units of VRTX stock worth $412,500 on 13 September 2011.
The largest trade Kenneth's ever made was exercising 22,000 units of Vertex Pharmaceuticals stock on 13 September 2011 worth over $412,500. On average, Kenneth trades about 4,359 units every 75 days since 2003. As of 13 September 2011 Kenneth still owns at least 134,999 units of Vertex Pharmaceuticals stock.
You can see the complete history of Kenneth Boger stock trades at the bottom of the page.
Kenneth's mailing address filed with the SEC is C/O VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY STREET, CAMBRIDGE, MA, 02139.
Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden, and Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: